Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12166141 | 0.75 | ALDH1A1 (0.35) | TSHR | |
| SCHEMBL4620572 | 0.73 | — | — | |
| SCHEMBL19329296 | 0.73 | TSHR (0.33) | TSHR | |
| SCHEMBL20490020 | 0.69 | TSHR (0.35) | TSHR | |
| SCHEMBL940382 | 0.69 | TP53 (0.40) | TSHR | |
| SCHEMBL4663699 | 0.69 | ALDH1A1 (0.36) | LMNA | |
| SCHEMBL7965203 | 0.67 | TDP1 (0.33) | TSHR | |
| SCHEMBL28898676 | 0.67 | TSHR (0.33) | TSHR | |
| SCHEMBL27522290 | 0.67 | CA1 (0.39) | TSHRLMNA | |
| SCHEMBL23185484 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006232-B2 | Pyrimidone derivatives | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-04-14 | — | — | US | disclosed |
| US-20120208797-A1 | PYRIMIDONE DERIVATIVES | SANOFI (FR) | 2012-08-16 | — | — | US | disclosed |
| EP-1391474-B1 | Substituted polyalkylene dioxythiophene as solid state electrolyte in electrolyte capacitors | STARCK H C GMBH (DE) | 2007-10-17 | — | — | EP | disclosed |
| EP-1391474-A1 | Substituted polyalkylene dioxythiophene as solid state electrolyte in electrolyte capacitors | H.C. Starck GmbH (DE) | 2004-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208797-A1 | PYRIMIDONE DERIVATIVES | PSEN1, PRNP, PSEN2 | TSHR 2385/4885LMNA 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.